相关实验视频

Updated: Jan 13, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

使用患者衍生的诱导多能干细胞预测与代谢功能障碍相关的脂肪性肝病风险

Yuanyuan Qin¹, Parth Chhetri¹, Elizabeth Theusch¹

¹Department of Pediatrics, University of California San Francisco, Oakland, CA 94609, United States.

Stem cells translational medicine

|January 9, 2026

概括

代谢功能障碍相关的脂肪性肝病 (MASLD) 可以使用一种新的诱导多能干细胞 (iPSCs) 测试来预测. 这种基于iPSC的风险评分通过测量脂质积累来识别具有较高MASLD风险的个体.

科学领域:

肝病学肝病学是一种肝病学.
干细胞生物学干细胞生物学
代谢疾病代谢疾病

背景情况:

与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题,强调了早期检测的必要性.
携带MASLD遗传风险变异的患者衍生诱导多能干细胞 (iPSC) 显示细胞内脂质积累增加.
早期识别MASLD至关重要,因为这种情况在初期阶段是可逆的.

研究的目的:

开发和验证基于iPSC的MASLD风险预测模型.
评估功能性脂质积累试验在iPSC中对MASLD风险预测的有用性.
通过使用油酸诱导的脂质积累来建立IPSC衍生的MASLD风险评分.

主要方法:

从三个不同的患者队列 (CIRM,POST,UCSF) 的iPSC中量化油酸诱导的脂质积累.
开发基于iPSC的MASLD风险评分,使用CIRM队列数据.
在独立的 POST 和 UCSF 队列中验证开发的风险评分.

主要成果:

与所有队列中的对照组相比,来自MASLD患者的IPSC始终表现出较高的油酸诱导脂质积累.
基于iPSC的MASLD风险评分显示出有希望的预测性表现,在POST队列中具有44%的灵敏度和75%的特异性.
风险评分在UCSF队列中实现了高准确性,显示75%的灵敏度和100%的特异性.

结论:

在iPSC中由油酸盐诱导的脂质积累可以作为预测MASLD风险的潜在生物标志物.
开发的基于iPSC的风险评分显示了早期MASLD识别和监测的潜力.
用更大的队列和各种数据类型进行进一步的研究可以完善这种方法对MASLD预防的预测准确性.

关键词:

马斯尔德马斯尔德是什么意思预防 MASLD 的预防.马斯德风险预测的风险预测这就是 iPSC 的意义.脂质的积累脂质的积累来自患者的iPSCs.

更多相关视频

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells

Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells

Published on: July 27, 2018

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...